NeXeption, LLC is a biopharmaceutical management company that brings together product opportunities, management expertise and the necessary funding to reach compelling partnership milestones. The NeXeption management team has a proven track record in raising capital, operating development stage companies and forming strategic partnerships to advance products for the benefit of patients.


JANUARY 27, 2015
Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Benign Skin Tumor

JANUARY 23, 2015
Alexar Awarded Michael J. Fox Foundation Grant for Research on a Novel Parkinson’s Disease Therapeutic

OCTOBER 2, 2014
Aclaris Therapeutics Closes $21 Million Series B Financing